Member of the Association of American Physicians
Barry G. W. Arnason spends much of his time researching Internal medicine, Multiple sclerosis, Immunology, Endocrinology and Pathology. The study incorporates disciplines such as Surgery, Expanded Disability Status Scale and Pharmacology in addition to Internal medicine. His Multiple sclerosis study combines topics from a wide range of disciplines, such as Gastroenterology, Molecular biology, Cerebrospinal fluid and Cytokine.
His research combines Central nervous system and Immunology. His Endocrinology research is multidisciplinary, incorporating elements of Receptor, Immune system and Sensitization. His Pathology research is multidisciplinary, incorporating perspectives in Acute motor sensory axonal neuropathy, Acute motor axonal neuropathy, Cell mediated immunity and Peripheral nerve.
Barry G. W. Arnason focuses on Immunology, Multiple sclerosis, Internal medicine, Endocrinology and Antibody. Immunology is a component of his Immune system, Antigen, Encephalomyelitis, Experimental allergic and Histocompatibility studies. His Multiple sclerosis study incorporates themes from Cerebrospinal fluid, Disease, Pathology and Central nervous system disease.
His biological study spans a wide range of topics, including Gastroenterology, In vitro, Surgery and Interferon beta-1b. His studies in Endocrinology integrate themes in fields like Concanavalin A, Receptor, Nerve growth factor and Neuroblastoma. In his research on the topic of Antibody, Monoclonal antibody is strongly related with Molecular biology.
His primary areas of study are Multiple sclerosis, Internal medicine, Immunology, Interferon beta-1b and Antibody. His Multiple sclerosis research is multidisciplinary, relying on both Disease and Oncology. His Internal medicine research includes themes of Gastroenterology, Surgery and Expanded Disability Status Scale.
His Immunology research incorporates elements of Myelin, Myelin basic protein and Virology. His research integrates issues of Nuclear medicine and Pharmacology in his study of Interferon beta-1b. His Antibody research integrates issues from Receptor, Nucleic acid, Interferon and Molecular biology.
His main research concerns Multiple sclerosis, Internal medicine, Glatiramer acetate, Expanded Disability Status Scale and Clinical trial. His research on Multiple sclerosis concerns the broader Immunology. His research in Immunology is mostly concerned with Immune system.
Barry G. W. Arnason focuses mostly in the field of Internal medicine, narrowing it down to topics relating to Surgery and, in certain cases, Gastroenterology, Secondary progressive multiple sclerosis, Neurology and Drug. Within one scientific family, he focuses on topics pertaining to Interferon beta-1b under Glatiramer acetate, and may sometimes address concerns connected to Follow up studies, Treatment outcome and Post hoc. His work carried out in the field of Expanded Disability Status Scale brings together such families of science as Clinical endpoint and Randomized controlled trial.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis.
Arthur K. Asbury;Barry G. Arnason;Raymond D. Adams.
Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument
D. F. Cella;K. Dineen;B. Arnason;A. Reder.
250 μg or 500 μg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
Paul O'Connor;Massimo Filippi;Barry Arnason;Giancarlo Comi.
Lancet Neurology (2009)
Glatiramer acetate in primary progressive multiple sclerosis: Results of a multinational, multicenter, double-blind, placebo-controlled trial
Jerry S. Wolinsky;Ponnada A. Narayana;Paul O'Connor;Patricia K. Coyle.
Annals of Neurology (2007)
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
Davide Maimone;Susan Gregory;Barry G.W. Arnason;Anthony T. Reder.
Journal of Neuroimmunology (1991)
S-100 protein in human chondrocytes.
K Stefansson;R L Wollmann;B W Moore;B G W Arnason.
ROLE OF THE THYMUS IN IMMUNE REACTIONS IN RATS : I. THE IMMUNOLOGIC RESPONSE TO BOVINE SERUM ALBUMIN (ANTIBODY FORMATION, ARTHUS REACTIVITY, AND DELAYED HYPERSENSITIVITY) IN RATS THYMECTOMIZED OR SPLENECTOMIZED AT VARIOUS TIMES AFTER BIRTH
Branislav D. Janković;Byron H. Waksman;Barry G. Arnason.
Journal of Experimental Medicine (1962)
Role of the thymus in immune reactions in rats. II. Suppressive effect of thymectomy at birth on reactions of delayed (cellular) hypersensitivity and the circulating small lymphocyte.
Barry G. Arnason;Branislav D. Janković;Byron H. Waksman;Christine Wennersten.
Journal of Experimental Medicine (1962)
Suppressor cell function in multiple sclerosis: Correlation with clinical disease activity
Jack P. Antel;Barry G. W. Arnason;M. Edward Medof.
Annals of Neurology (1979)
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci
Nikolaos A. Patsopoulos;Federica Esposito;Joachim Reischl;Stephan Lehr.
Annals of Neurology (2011)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: